Archives for August 23, 2016

CPhI South Korea 2016

Accelerating timelines vital to securing slice of biosimilars market, KBI

24-Aug-2016

By Dan Stanton

Accelerated development gives biosimilars an upper hand in gaining market share, CMO KBI Biopharma told delegates in Korea yesterday.

update - Hospira regrets non-compliance

24-Aug-2016

By Gareth Macdonald

Pfizer’s Hospira unit and Napp Pharmaceuticals broke ABPI rules covering the promotion of biosimilar medicines according to the UK industry group.